2022-11-24 | TSXV:NRX | Press Release | NurExone Biologic Inc.
(2022-11-24 | TSXV:NRX) NurExone Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Stay updated with breaking news from Filing Statement. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
(2022-11-24 | TSXV:NRX) NurExone Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Calgary, Alberta--(Newsfile Corp. - November 24, 2022) - NurExone Biologic Inc. (TSXV: NRX) (FSE: J90) (the "Company" or "NurExone"), a biopharmaceutical company developing biologically-guided exosome
VICTORY SQUARE'S SUBSIDIARY, IV HYDREIGHT ANNOUNCES RECEIPT OF TSXV CONDITIONAL APPROVAL, FILING OF FILING STATEMENT AND CLOSING OF PRIVATE PLACEMENTS Not for distribution to... | November 14, 2022
Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or indirectly, in whole or in part,
/PRNewswire/ - Liquid Meta Capital Holdings Ltd. ("Liquid Meta" or the "Company") (NEO: LIQD) (FRANKFURT: N5F) (OTCQB: LIQQF) a decentralized finance...